Home / Distigmine / Germany
DE ATC N07AA03 · updated 2 Nov 2026
Distigmine shortage in Germany
Is there a Distigmine shortage in Germany?
Yes. As of 2 Nov 2026, 2 Distigmine products are reported short in Germany, the first since 30 Jan 2025. The company estimate for the return is 31 Dec 2026. Main reason: active ingredient shortage.
Also short in Czechia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Ubretid Tabletten | Cheplapharm Arzneimittel GmbH | 30 Jan 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Ubretid Tabletten | Cheplapharm Arzneimittel GmbH | 30 Jan 2025 | 31 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.